Lb Pharmaceuticals (LBRX) Depreciation and Depletion (2025 - 2026)
Lb Pharmaceuticals' (LBRX) quarterly Depreciation and Depletion came in at $82000.0 in Q1 2026, up 3.8% year-on-year from $79000.0 in Q1 2025, and up 3.8% quarter-over-quarter from $79000.0 in Q1 2025.
Lb Pharmaceuticals (LBRX) Depreciation and Depletion (2025 - 2026) Analysis & Trends
Lb Pharmaceuticals' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $82000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,734.26 Bn | 65,733.97 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,919.96 Bn | 1,919.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.76 Bn | 465.97 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.97 Bn | 61.22 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.72 Bn | 50.53 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | - |
| 10 | Lb Pharmaceuticals | 982.25 Mn | 982.25 Mn | - | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |